New vaccine could slow child-killer disease
New York
A NEW vaccine against a diarrhoeal disease that kills about 600 children a day worked well in a large trial in Africa and appears to be a practical way to protect millions of children, scientists said on Wednesday.
The new vaccine against rotavirus, the most common cause of death from diarrhoea in children under age five, is made by an Indian company and was tested in Niger by Doctors Without Borders.
The vaccine is expected to be as cheap as or cheaper than alternatives. More important, it can last for months without refrigeration, which makes it far easier to use in remote villages with no electricity.
It must be approved by the World Health …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO